Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Universal screening and drug treatment of dyslipidemia in children and adolescents.

Psaty BM, Rivara FP.

JAMA. 2012 Jan 18;307(3):257-8. doi: 10.1001/jama.2011.1916. Epub 2011 Dec 15. No abstract available.

PMID:
22174386
2.

[Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].

Shoji T.

Nihon Jinzo Gakkai Shi. 2013;55(7):1267-75. Review. Japanese. No abstract available.

PMID:
24288962
3.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799
4.

The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.

Ahmed MH, Al-Atta A, Hamad MA.

Expert Opin Pharmacother. 2012 Sep;13(13):1901-9. doi: 10.1517/14656566.2012.706604. Epub 2012 Jul 7. Review.

PMID:
22770622
5.

Assessment of low-density lipoprotein targets.

Whayne TF Jr.

Angiology. 2013 Aug;64(6):411-6. doi: 10.1177/0003319712451115. Epub 2012 Jun 25. Review.

PMID:
22734087
6.

Screening and treatment of dyslipidemias in children and adolescents.

Daniels SR.

Horm Res Paediatr. 2011;76 Suppl 1:47-51. doi: 10.1159/000329163. Epub 2011 Jul 21. Review.

PMID:
21778749
7.

The new dyslipidemia guidelines: what is the debate?

Anderson TJ, Mancini GB, Genest J Jr, Grégoire J, Lonn EM, Hegele RA.

Can J Cardiol. 2015 May;31(5):605-12. doi: 10.1016/j.cjca.2014.11.007. Epub 2014 Nov 11. Review.

PMID:
25816728
8.

An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.

Expert Panel on Dyslipidemia.

Atherosclerosis. 2014 Feb;232(2):410-3. doi: 10.1016/j.atherosclerosis.2013.11.031. Epub 2013 Nov 28. Review. No abstract available.

PMID:
24468156
9.

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

de Nijs T, Sniderman A, de Graaf J.

Crit Rev Clin Lab Sci. 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. Review.

PMID:
24295059
10.

Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.

Virani SS.

Tex Heart Inst J. 2013;40(3):288-9. Review. No abstract available.

11.

[Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].

Båvenholm P, Attvall S, Nilsson PM.

Lakartidningen. 2006 Aug 30-Sep 5;103(35):2462-6. Review. Swedish. No abstract available.

PMID:
17002161
12.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
13.

Lipid, blood pressure and kidney update 2013.

Banach M, Serban C, Aronow WS, Rysz J, Dragan S, Lerma EV, Apetrii M, Covic A.

Int Urol Nephrol. 2014 May;46(5):947-61. doi: 10.1007/s11255-014-0657-6. Epub 2014 Feb 27. Review.

14.

High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.

Gonzalez GL, Manrique CM, Sowers JR.

J Cardiometab Syndr. 2006 Summer;1(3):178-83. Review.

15.

Efficacy and safety of rosuvastatin in the management of dyslipidemia.

Rubba P, Marotta G, Gentile M.

Vasc Health Risk Manag. 2009;5(1):343-52. Epub 2009 Apr 8. Review.

16.

In the clinic. Dyslipidemia.

Kopin LA, Pearson TA.

Ann Intern Med. 2007 Sep 4;147(5):ITC9-1-ITC9-16. Review. No abstract available. Erratum in: Ann Intern Med. 2008 Mar 4;148(5):407-8.

PMID:
17785482
17.

Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.

Chehade JM, Gladysz M, Mooradian AD.

Drugs. 2013 Mar;73(4):327-39. doi: 10.1007/s40265-013-0023-5. Review.

PMID:
23479408
18.

Dyslipidemia and cardiovascular disease in women.

Cífková R, Krajčoviechová A.

Curr Cardiol Rep. 2015 Jul;17(7):609. doi: 10.1007/s11886-015-0609-5. Review.

PMID:
26026998
19.
20.

[Lipid management--treatment goal and strategy].

Koshiyama H.

Nihon Rinsho. 2006 Nov;64(11):2102-6. Review. Japanese.

PMID:
17087303

Supplemental Content

Support Center